跳到正文
AiSeekAiSeek
登录

公司

Perspective Therapeutics, Inc.

关注打开结构图就此提问研究这家公司

Perspective Therapeutics, Inc. 的结构

Perspective Therapeutics, Inc.

公司

4 个关联
上游供应与依赖
自有产品与技术
关系出现时间2026
Perspective Therapeutics, Inc.公司 · 4 个关联
第 1 层

上游供应与依赖3

自有产品与技术1

关系

箭头表示关系方向，可按业务类别筛选。

  • Perspective Therapeutics, Inc.使用 →Lead-212 (²¹²Pb)
    材料 · Lead-212 (²¹²Pb)证据 1
    事实90%
    查看证据
    • 公司披露GlobeNewswire public company news2026-10-07 18:16
      The Company has proprietary technology that utilizes the alpha-generating isotope <sup>212</sup>Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
      查看来源
  • Perspective Therapeutics, Inc.使用 →Lead-212
    材料 · Lead-212证据 1
    事实90%
    查看证据
    • 公司披露GlobeNewswire public company news2026-10-08 18:16
      The Company has proprietary technology that utilizes the alpha-generating isotope <sup>212</sup>Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
      查看来源
  • Perspective Therapeutics, Inc.制造 →Clinical drug product candidates
    产品 · Clinical drug product candidates证据 1
    事实90%
    查看证据
    • 公司披露GlobeNewswire public company news2026-10-08 18:16
      its proprietary <sup>224</sup>Ra/<sup>212</sup>Pb generator platform used to manufacture clinical drug product candidates
      查看来源
  • Perspective Therapeutics, Inc.使用 →Radium-224/Lead-212 generator platform
    技术 · Radium-224/Lead-212 generator platform证据 1
    事实90%
    查看证据
    • 公司披露GlobeNewswire public company news2026-10-08 18:16
      its proprietary <sup>224</sup>Ra/<sup>212</sup>Pb generator platform used to manufacture clinical drug product candidates
      查看来源

显示第 1 至 4 条，共 4 条

结论

结合来源阅读结论，展开条目查看证据。

事实证据 1
使用Lead-212

The Company has proprietary technology that utilizes the alpha-generating isotope <sup>212</sup>Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

GlobeNewswire public company news · 2026-10-08 18:16

查看证据
  • 公司披露GlobeNewswire public company news2026-10-08 18:16
    The Company has proprietary technology that utilizes the alpha-generating isotope <sup>212</sup>Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
    查看来源
事实证据 1
制造Clinical drug product candidates

its proprietary <sup>224</sup>Ra/<sup>212</sup>Pb generator platform used to manufacture clinical drug product candidates

GlobeNewswire public company news · 2026-10-08 18:16

查看证据
  • 公司披露GlobeNewswire public company news2026-10-08 18:16
    its proprietary <sup>224</sup>Ra/<sup>212</sup>Pb generator platform used to manufacture clinical drug product candidates
    查看来源
事实证据 1
使用Radium-224/Lead-212 generator platform

its proprietary <sup>224</sup>Ra/<sup>212</sup>Pb generator platform used to manufacture clinical drug product candidates

GlobeNewswire public company news · 2026-10-08 18:16

查看证据
  • 公司披露GlobeNewswire public company news2026-10-08 18:16
    its proprietary <sup>224</sup>Ra/<sup>212</sup>Pb generator platform used to manufacture clinical drug product candidates
    查看来源
事实证据 1
使用Lead-212 (²¹²Pb)

The Company has proprietary technology that utilizes the alpha-generating isotope <sup>212</sup>Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

GlobeNewswire public company news · 2026-10-07 18:16

查看证据
  • 公司披露GlobeNewswire public company news2026-10-07 18:16
    The Company has proprietary technology that utilizes the alpha-generating isotope <sup>212</sup>Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
    查看来源

显示第 1 至 4 条，共 4 条

市场与估值

估值数据需要 Pro 或 Research。

升级到 Pro 解锁

暂无: 公司信号 · 财务数据 · 披露文件 · 业绩指引